Law Assistant Dean leads community conversation on educational equity

 

The Office of Research at the University of Cincinnati and the Cincinnati Ethics Center tapped Assistant Dean Na’Tasha Webb-Prather to lead a conversation on educational equity as a preview to Research and Innovation Week. The preview events were designed to challenge thinking through ethical issues related to how we educate ourselves and broader societal issues about access to education for everyone.

Take a moment to view Webb-Prather’s interactive conversation, held Thursday, March 24, 2022.

Assistant Dean Na'Tasha Webb-Prather

Assistant Dean Na'Tasha Webb-Prather

In her role as assistant dean of student life, community engagement, and equity at the College of Law, Webb-Prather oversees the law school’s student affairs program and is  responsible for facilitating student access to academic, co-curricular and social activities at the university. Previously, she was an equity and compliance administrator and worked at the Board of Regents of the University System of Georgia.

The university’s week-long R + I event, March 28-April 1, 2022, will include a series of events examining various aspects of ethics—ethics and equity in academic publishing, ethical issues with cryptocurrency, the global crisis in knowledge production, and leadership. Check their schedule for more information about events and how you can participate.

All events are free and open to the general public.

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.